[The efficacy of combined therapy with immunodepressants, anticoagulants and antiaggregants in certain clinico-morphological variants of chronic glomerulonephritis].
Ratner
M Ia
MIa
Biriukova
L S
LS
Makurov
A I
AI
D000925:Anticoagulants / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000453:epidemiology; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy / Q000453:epidemiology; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D013997:Time Factors
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors
Effektivnost' kombinirovannoĭ terapii immunodepressantami, antikoaguliantami i antiagregantami pri opredelennykh kliniko-morfologicheskikh variantakh khronicheskogo glomerulonefrita.